Transnetyx
Whitney Heffernan is an accomplished Sales Operations Account Manager at Transnetyx since September 2023 and has served as the Director of Marketing for D-PATH at PathAI Diagnostics since February 2016. In this role, responsibilities include developing and executing strategic marketing plans, conducting financial analysis for customer partnerships, and managing the Digital Pathology platform. Previous experience includes positions at Harmonyx Diagnostics, where significant achievements encompassed account management, training, and sales strategy development, as well as a Senior Territory Business Manager role at Bristol-Myers Squibb, where sales goals were consistently achieved. Whitney holds a Bachelor of Science in Biology from The University of Memphis and the University of Tennessee, Knoxville.
Transnetyx
1 followers
Transnetyx is an automated genotyping company dedicated to serving research and saving time by removing redundant, yet necessary, tests conducted in genetic research. By optimizing resources, Transnetyx has paved the way for research to advance and deeper understandings to emerge. Founded in 2000 and headquartered in Memphis, Tenn., Transnetyx launched the world’s first fully-automated genotyping system for detecting transgenic, knockout, knock-in, SNP and CRISPR mutations in animal research models. Transnetyx has genotyped more than 25 million samples worldwide in 24 or 72 hours with 99.97 percent accuracy. It has built a genetic database of more than 20,000 assays and is the trusted genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. The mission of Transnetyx, then and now, is to help scientists accelerate research with fast, easy and accurate genotyping services. For more information, visit transnetyx.com. For current job openings, visit transnetyx.com/careers.